State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Non-Hodgkin Lymphoma (Late Stage^), 2017-2021

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by Rate

Explanation of Column Headers

Objective - The objective of *** is from the Healthy People 2020 project done by the Centers for Disease Control and Prevention.

Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 12.0 with a 95% confidence interval from 12.0 to 12.1 and 46,520 average annual cases over 2017-2021.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 65.0

Iowa³

• Rate : The incidence rate is 14.9 with a 95% confidence interval from 14.3 to 15.4 and 591 average annual cases over 2017-2021.
• CI*Rank ⋔ : 1 (1, 3)
• Percent of Cases with Late Stage : 70.1

Wisconsin⁶

• Rate : The incidence rate is 14.2 with a 95% confidence interval from 13.8 to 14.6 and 1,057 average annual cases over 2017-2021.
• CI*Rank ⋔ : 2 (1, 6)
• Percent of Cases with Late Stage : 69.8

Minnesota⁶

• Rate : The incidence rate is 14.1 with a 95% confidence interval from 13.6 to 14.5 and 963 average annual cases over 2017-2021.
• CI*Rank ⋔ : 3 (1, 8)
• Percent of Cases with Late Stage : 63.6

Maine⁶

• Rate : The incidence rate is 13.6 with a 95% confidence interval from 12.9 to 14.4 and 271 average annual cases over 2017-2021.
• CI*Rank ⋔ : 4 (1, 22)
• Percent of Cases with Late Stage : 70.2

Kentucky³

• Rate : The incidence rate is 13.6 with a 95% confidence interval from 13.2 to 14.1 and 750 average annual cases over 2017-2021.
• CI*Rank ⋔ : 5 (2, 14)
• Percent of Cases with Late Stage : 69.9

West Virginia⁶

• Rate : The incidence rate is 13.6 with a 95% confidence interval from 12.9 to 14.3 and 341 average annual cases over 2017-2021.
• CI*Rank ⋔ : 6 (2, 21)
• Percent of Cases with Late Stage : 69.8

Ohio⁶

• Rate : The incidence rate is 13.4 with a 95% confidence interval from 13.1 to 13.7 and 1,982 average annual cases over 2017-2021.
• CI*Rank ⋔ : 7 (4, 13)
• Percent of Cases with Late Stage : 70.4

Connecticut³

• Rate : The incidence rate is 13.4 with a 95% confidence interval from 12.9 to 13.8 and 617 average annual cases over 2017-2021.
• CI*Rank ⋔ : 8 (3, 20)
• Percent of Cases with Late Stage : 65.3

South Dakota⁶

• Rate : The incidence rate is 13.3 with a 95% confidence interval from 12.3 to 14.3 and 143 average annual cases over 2017-2021.
• CI*Rank ⋔ : 9 (1, 33)
• Percent of Cases with Late Stage : 69.2

North Dakota⁶

• Rate : The incidence rate is 13.2 with a 95% confidence interval from 12.1 to 14.3 and 116 average annual cases over 2017-2021.
• CI*Rank ⋔ : 10 (1, 35)
• Percent of Cases with Late Stage : 68.0

Pennsylvania⁶

• Rate : The incidence rate is 13.1 with a 95% confidence interval from 12.8 to 13.4 and 2,241 average annual cases over 2017-2021.
• CI*Rank ⋔ : 11 (5, 18)
• Percent of Cases with Late Stage : 68.2

New Jersey³

• Rate : The incidence rate is 12.9 with a 95% confidence interval from 12.6 to 13.2 and 1,462 average annual cases over 2017-2021.
• CI*Rank ⋔ : 12 (7, 24)
• Percent of Cases with Late Stage : 62.0

New York³

• Rate : The incidence rate is 12.9 with a 95% confidence interval from 12.7 to 13.1 and 3,185 average annual cases over 2017-2021.
• CI*Rank ⋔ : 13 (8, 22)
• Percent of Cases with Late Stage : 63.4

Idaho³

• Rate : The incidence rate is 12.8 with a 95% confidence interval from 12.1 to 13.5 and 273 average annual cases over 2017-2021.
• CI*Rank ⋔ : 14 (4, 33)
• Percent of Cases with Late Stage : 68.6

Nebraska⁶

• Rate : The incidence rate is 12.8 with a 95% confidence interval from 12.1 to 13.5 and 291 average annual cases over 2017-2021.
• CI*Rank ⋔ : 15 (4, 33)
• Percent of Cases with Late Stage : 66.0

Illinois³

• Rate : The incidence rate is 12.7 with a 95% confidence interval from 12.4 to 13.0 and 1,933 average annual cases over 2017-2021.
• CI*Rank ⋔ : 16 (10, 27)
• Percent of Cases with Late Stage : 67.3

Missouri⁶

• Rate : The incidence rate is 12.7 with a 95% confidence interval from 12.3 to 13.1 and 974 average annual cases over 2017-2021.
• CI*Rank ⋔ : 17 (8, 29)
• Percent of Cases with Late Stage : 70.2

Louisiana³

• Rate : The incidence rate is 12.6 with a 95% confidence interval from 12.2 to 13.1 and 682 average annual cases over 2017-2021.
• CI*Rank ⋔ : 18 (8, 31)
• Percent of Cases with Late Stage : 66.9

Utah³

• Rate : The incidence rate is 12.6 with a 95% confidence interval from 12.0 to 13.2 and 362 average annual cases over 2017-2021.
• CI*Rank ⋔ : 19 (6, 33)
• Percent of Cases with Late Stage : 68.2

New Hampshire⁶

• Rate : The incidence rate is 12.5 with a 95% confidence interval from 11.8 to 13.3 and 231 average annual cases over 2017-2021.
• CI*Rank ⋔ : 20 (5, 36)
• Percent of Cases with Late Stage : 62.5

Michigan⁶

• Rate : The incidence rate is 12.5 with a 95% confidence interval from 12.2 to 12.8 and 1,580 average annual cases over 2017-2021.
• CI*Rank ⋔ : 21 (12, 30)
• Percent of Cases with Late Stage : 67.8

Vermont⁶

• Rate : The incidence rate is 12.5 with a 95% confidence interval from 11.4 to 13.6 and 114 average annual cases over 2017-2021.
• CI*Rank ⋔ : 22 (3, 39)
• Percent of Cases with Late Stage : 67.6

Washington⁵

• Rate : The incidence rate is 12.5 with a 95% confidence interval from 12.1 to 12.8 and 1,107 average annual cases over 2017-2021.
• CI*Rank ⋔ : 23 (12, 31)
• Percent of Cases with Late Stage : 65.7

North Carolina⁶

• Rate : The incidence rate is 12.4 with a 95% confidence interval from 12.1 to 12.7 and 1,550 average annual cases over 2017-2021.
• CI*Rank ⋔ : 25 (14, 30)
• Percent of Cases with Late Stage : 69.1

Montana⁶

• Rate : The incidence rate is 12.3 with a 95% confidence interval from 11.5 to 13.2 and 176 average annual cases over 2017-2021.
• CI*Rank ⋔ : 26 (5, 38)
• Percent of Cases with Late Stage : 70.9

Rhode Island⁶

• Rate : The incidence rate is 12.3 with a 95% confidence interval from 11.5 to 13.2 and 171 average annual cases over 2017-2021.
• CI*Rank ⋔ : 27 (6, 38)
• Percent of Cases with Late Stage : 66.4

Kansas⁶

• Rate : The incidence rate is 12.3 with a 95% confidence interval from 11.7 to 12.8 and 425 average annual cases over 2017-2021.
• CI*Rank ⋔ : 28 (10, 35)
• Percent of Cases with Late Stage : 66.4

Florida⁶

• Rate : The incidence rate is 12.1 with a 95% confidence interval from 12.0 to 12.3 and 3,616 average annual cases over 2017-2021.
• CI*Rank ⋔ : 29 (22, 32)
• Percent of Cases with Late Stage : 55.5

California³

• Rate : The incidence rate is 11.9 with a 95% confidence interval from 11.8 to 12.0 and 5,226 average annual cases over 2017-2021.
• CI*Rank ⋔ : 30 (27, 35)
• Percent of Cases with Late Stage : 67.4

Delaware⁶

• Rate : The incidence rate is 11.9 with a 95% confidence interval from 11.0 to 12.8 and 158 average annual cases over 2017-2021.
• CI*Rank ⋔ : 31 (9, 40)
• Percent of Cases with Late Stage : 69.9

Alaska⁶

• Rate : The incidence rate is 11.9 with a 95% confidence interval from 10.7 to 13.1 and 85 average annual cases over 2017-2021.
• CI*Rank ⋔ : 32 (4, 43)
• Percent of Cases with Late Stage : 66.4

Oregon⁶

• Rate : The incidence rate is 11.8 with a 95% confidence interval from 11.4 to 12.3 and 629 average annual cases over 2017-2021.
• CI*Rank ⋔ : 33 (22, 37)
• Percent of Cases with Late Stage : 66.0

Maryland⁶

• Rate : The incidence rate is 11.8 with a 95% confidence interval from 11.4 to 12.2 and 864 average annual cases over 2017-2021.
• CI*Rank ⋔ : 34 (24, 37)
• Percent of Cases with Late Stage : 67.7

Georgia³

• Rate : The incidence rate is 11.6 with a 95% confidence interval from 11.3 to 11.9 and 1,336 average annual cases over 2017-2021.
• CI*Rank ⋔ : 35 (29, 37)
• Percent of Cases with Late Stage : 66.9

Oklahoma⁶

• Rate : The incidence rate is 11.4 with a 95% confidence interval from 11.0 to 11.9 and 525 average annual cases over 2017-2021.
• CI*Rank ⋔ : 36 (28, 40)
• Percent of Cases with Late Stage : 65.9

Colorado⁶

• Rate : The incidence rate is 11.4 with a 95% confidence interval from 11.0 to 11.7 and 713 average annual cases over 2017-2021.
• CI*Rank ⋔ : 37 (30, 39)
• Percent of Cases with Late Stage : 68.9

Texas³

• Rate : The incidence rate is 11.0 with a 95% confidence interval from 10.8 to 11.1 and 3,177 average annual cases over 2017-2021.
• CI*Rank ⋔ : 38 (36, 40)
• Percent of Cases with Late Stage : 62.5

Arkansas⁶

• Rate : The incidence rate is 10.9 with a 95% confidence interval from 10.4 to 11.4 and 407 average annual cases over 2017-2021.
• CI*Rank ⋔ : 39 (33, 44)
• Percent of Cases with Late Stage : 62.9

Virginia⁶

• Rate : The incidence rate is 10.5 with a 95% confidence interval from 10.2 to 10.8 and 1,062 average annual cases over 2017-2021.
• CI*Rank ⋔ : 40 (38, 44)
• Percent of Cases with Late Stage : 64.2

Tennessee⁶

• Rate : The incidence rate is 10.5 with a 95% confidence interval from 10.2 to 10.8 and 871 average annual cases over 2017-2021.
• CI*Rank ⋔ : 41 (38, 45)
• Percent of Cases with Late Stage : 60.8

South Carolina⁶

• Rate : The incidence rate is 10.3 with a 95% confidence interval from 9.9 to 10.6 and 656 average annual cases over 2017-2021.
• CI*Rank ⋔ : 42 (39, 46)
• Percent of Cases with Late Stage : 64.9

Mississippi⁶

• Rate : The incidence rate is 10.2 with a 95% confidence interval from 9.7 to 10.7 and 356 average annual cases over 2017-2021.
• CI*Rank ⋔ : 43 (38, 47)
• Percent of Cases with Late Stage : 62.8

Hawaii³

• Rate : The incidence rate is 9.8 with a 95% confidence interval from 9.2 to 10.5 and 187 average annual cases over 2017-2021.
• CI*Rank ⋔ : 44 (39, 48)
• Percent of Cases with Late Stage : 64.3

Arizona⁶

• Rate : The incidence rate is 9.6 with a 95% confidence interval from 9.3 to 9.9 and 851 average annual cases over 2017-2021.
• CI*Rank ⋔ : 45 (43, 48)
• Percent of Cases with Late Stage : 63.1

Wyoming⁶

• Rate : The incidence rate is 9.6 with a 95% confidence interval from 8.5 to 10.7 and 67 average annual cases over 2017-2021.
• CI*Rank ⋔ : 46 (37, 49)
• Percent of Cases with Late Stage : 60.0

District of Columbia⁶

• Rate : The incidence rate is 9.5 with a 95% confidence interval from 8.5 to 10.6 and 64 average annual cases over 2017-2021.
• CI*Rank ⋔ : 47 (38, 49)
• Percent of Cases with Late Stage : 60.5

Alabama⁶

• Rate : The incidence rate is 9.2 with a 95% confidence interval from 8.8 to 9.5 and 567 average annual cases over 2017-2021.
• CI*Rank ⋔ : 48 (44, 48)
• Percent of Cases with Late Stage : 63.8

Nevada⁶

• Rate : The incidence rate is 8.2 with a 95% confidence interval from 7.8 to 8.7 and 295 average annual cases over 2017-2021.
• CI*Rank ⋔ : 49 (48, 50)
• Percent of Cases with Late Stage : 56.6

New Mexico³

• Rate : The incidence rate is 7.9 with a 95% confidence interval from 7.4 to 8.4 and 208 average annual cases over 2017-2021.
• CI*Rank ⋔ : 50 (48, 50)
• Percent of Cases with Late Stage : 55.5

Puerto Rico⁶

• Rate : The incidence rate is 5.5 with a 95% confidence interval from 5.1 to 5.8 and 222 average annual cases over 2017-2021.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : 39.8

Indiana⁶

• Rate : Data not available for this combination of data selections.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage : data not available

Notes:
Created by statecancerprofiles.cancer.gov on 10/06/2024 3:25 pm.

State Cancer Registries may provide more current or more local data.

Data cannot be shown for the following areas. For more information on what areas are suppressed or not available, please refer to the table.
Indiana

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (19 age groups: <1, 1-4, 5-9, ... , 80-84, 85+). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.
Data not available for this combination of data selections.
Source: SEER and NPCR data. For more specific information please see the table.

Data for the United States does not include data from Indiana.
Data for the United States does not include Puerto Rico.